Novartis Announces Acquisition of MorphoSys for $2.9 Billion
In a strategic move aimed at bolstering its cancer treatment portfolio, Novartis AG has declared its intention to acquire MorphoSys…
In a strategic move aimed at bolstering its cancer treatment portfolio, Novartis AG has declared its intention to acquire MorphoSys…